DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications

Pharmacology & Therapeutics
Ramzi AbbassiLenka Munoz

Abstract

Protein kinases are one of the most studied drug targets in current pharmacological research, as evidenced by the vast number of kinase-targeting agents enrolled in active clinical trials. Dual-specificity Tyrosine phosphorylation-Regulated Kinase 1A (DYRK1A) has been much less studied compared to many other kinases. DYRK1A primary function occurs during early development, where this protein regulates cellular processes related to proliferation and differentiation of neuronal progenitor cells. Although most extensively characterised for its role in brain development, DYRK1A is over-expressed in a variety of diseases including a number of human malignancies, such as haematological and brain cancers. Here we review the accumulating molecular studies that support our understanding of how DYRK1A signalling could underlie these pathological functions. The relevance of DYRK1A in a number of diseases is also substantiated with intensive drug discovery efforts to develop potent and selective inhibitors of DYRK1A. Several classes of DYRK1A inhibitors have recently been disclosed and some molecules are promising leads to develop DYRK1A inhibitors as drugs for DYRK1A-dependent diseases.

References

Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R AlboresM A Collins
Jan 1, 1997·Archives of Biochemistry and Biophysics·H KimR R Ramsay
Jan 25, 2000·The Journal of Biological Chemistry·S HimpelW Becker
Jan 22, 2003·The Biochemical Journal·Jenny BainPhilip Cohen
Jun 7, 2003·Nature Cell Biology·Lindsey A AllanPaul R Clarke
Mar 24, 2006·Nature·Joseph R ArronGerald R Crabtree
May 18, 2006·Genes & Development·Laurent NguyenFrançois Guillemot
Aug 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mi-Young KimKyung Keun Kim
Jan 19, 2007·Molecular Biology of the Cell·Mónica AlvarezSusana de la Luna
Feb 13, 2007·International Journal of Cancer. Journal International Du Cancer·Hung-Shu ChangWinston C Y Yu
Aug 28, 2007·Molecular and Cellular Neurosciences·Joongkyu ParkKwang Chul Chung
Sep 14, 2007·The Biochemical Journal·Jenny BainPhilip Cohen
May 30, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fei LiuCheng-Xin Gong
Apr 23, 2009·Journal of Cell Science·Javier Fernandez-MartinezJuan Galceran
Aug 18, 2009·Cellular and Molecular Life Sciences : CMLS·Joongkyu ParkKwang Chul Chung
Sep 29, 2009·Current Opinion in Cell Biology·Ryoichiro KageyamaItaru Imayoshi
Oct 6, 2009·The Journal of Biological Chemistry·Youngkyun LeeHong-Hee Kim
Feb 20, 2010·The Journal of Biological Chemistry·Xiumei GuoXiaoling Li
Mar 20, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Odessa YabutGabriella D'Arcangelo
Aug 11, 2010·The Journal of Biological Chemistry·Joongkyu ParkKwang Chul Chung
Aug 14, 2010·Cell·Michael J MoorePamela A Silver
Oct 29, 2010·Nature Communications·Yasushi OgawaMasatoshi Hagiwara
Dec 16, 2010·The FEBS Journal·Francisco J Tejedor, Barbara Hämmerle
Dec 16, 2010·The FEBS Journal·Jerzy WegielYu-Wen Hwang
Dec 25, 2010·Bioorganic & Medicinal Chemistry·J ReniersJ Wouters
Apr 8, 2011·Nucleic Acids Research·Wei QianFei Liu
Apr 19, 2011·Genes & Development·Larisa LitovchickJames A DeCaprio

❮ Previous
Next ❯

Citations

Jun 16, 2016·Lancet Neurology·Clive BallardAnne Corbett
Apr 14, 2016·Future Medicinal Chemistry·Silvia StotaniFederico Medda
May 6, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Damien HédouThierry Besson
Jun 16, 2016·Frontiers in Cell and Developmental Biology·Berta Casar, Piero Crespo
Sep 13, 2016·Diabetes, Obesity & Metabolism·J Shirakawa, R N Kulkarni
Feb 9, 2017·Future Medicinal Chemistry·Hendra GunosewoyoMichael Kassiou
Mar 18, 2017·SLAS Discovery·Narayan D ChaurasiyaBabu L Tekwani
Jan 5, 2017·Chemical & Pharmaceutical Bulletin·Meropi SklepariSandrine Ruchaud
Jun 26, 2017·Neurobiology of Disease·Susana García-CerroCarmen Martínez-Cué
Jun 9, 2016·Chemical Communications : Chem Comm·Enrico FaggiIgnacio Alfonso
Mar 6, 2018·Current Psychiatry Reports·Alexander C Conley, Paul A Newhouse
Jan 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosanna MeineConrad Kunick
Aug 31, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Florence CoulyThierry Besson
Mar 29, 2016·F1000Research·Annette Karmiloff-SmithAndre Strydom
May 1, 2019·International Journal of Molecular Sciences·Gianmarco PallaviciniFerdinando Di Cunto
Sep 2, 2020·Cellular and Molecular Life Sciences : CMLS·Amina Jamal LahamRaafat El-Awady
May 9, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fei MaZhiyong Zhang
Jun 27, 2018·Frontiers in Oncology·Audra N Iness, Larisa Litovchick
Mar 11, 2017·Nature Reviews. Drug Discovery·Lenka Munoz
Aug 3, 2017·Expert Opinion on Therapeutic Patents·Thu Lan NguyenThierry Besson
Nov 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Christian LechnerConrad Kunick
Sep 23, 2020·International Journal of Molecular Sciences·Hye Ree YoonNam Sook Kang
Jan 5, 2021·The Journal of Clinical Investigation·Rahul S BhansaliJohn D Crispino
Jul 13, 2020·Research in Developmental Disabilities·Michael S C ThomasUNKNOWN LonDownS Consortium
Feb 2, 2021·Brain Injury : [BI]·Svetlana V Demyanenko, Anatoly Uzdensky
Feb 14, 2021·Journal of Molecular Neuroscience : MN·Ruixia ZhuXu Liu
Nov 19, 2020·Archives of Pharmacal Research·Liang ZhangShenglan Yu
Jan 29, 2021·World Journal of Stem Cells·Nikolaos Kokkorakis, Maria Gaitanou
Feb 23, 2021·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Haizhou ZhuSwati S More
Mar 31, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Michael TarpleyKevin P Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The FEBS Journal
Walter Becker, Wolfgang Sippl
Trends in Pharmacological Sciences
Mathias Rask-AndersenHelgi B Schiöth
British Journal of Pharmacology
Concetta Bubici, Salvatore Papa
Cellular and Molecular Life Sciences : CMLS
Joongkyu ParkKwang Chul Chung
© 2021 Meta ULC. All rights reserved